Purification of immunoglobulin G-based biopharmaceuticals using supported ionic liquids

Detalhes bibliográficos
Autor(a) principal: Castro, Mariana Meireles e
Data de Publicação: 2022
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/37160
Resumo: Antibodies are responsible for the humoral response and belong to the adaptive processes of the immune system. These properties distinguish antibodies, such as immunoglobulin G (IgG), as important proteins for scientific and clinical research, especially in the treatment of various diseases and in a variety of diagnostic tests. Thus, the production of therapeutic antibodies must be subject to strict criteria of efficiency and safety, which requires a high degree of purity. However, this process is associated with a high cost, due to the currently used downstream processing, which has been a major obstacle to the widespread application of antibodies. Therefore, the development of new cost-effective methods is crucial, where solid phase extraction has proven to be effective. Thus, in this work, resin-based supported ionic liquids (SILs) were investigated for the extraction and purification of IgG polyclonal antibodies, and the effect of the chemical structure of the ionic liquids (ILs), the operating conditions of extraction and purification were optimized to improve IgG yield and purity. In this dissertation, SILs ([MERR][C₁C₁im]Cl (1), ([MERR][C₁C₁im]Cl (2), and [MERR][N₁₈₈₈]Cl) were first synthesized and characterized. Then, a study was carried out with pure solutions of IgG and HSA to evaluate the adsorption capacity on SILs. For this assay, the best result in the adsorption of pure IgG was for Merrifield resin (pH 7, 75-fold dilution), with adsorption yield on the material of 96, 1%. Subsequently, the adsorption was studied in a binary mixture of IgG and HSA, with a purification value obtained of 1.77 for the IgG adsorbed on the material [MERR][C₁C₁im]Cl (1), at pH 4 and 50-fold dilution. Finally, the operational conditions for adsorption of IgG in human serum were studied and optimized, namely the effect of material synthesis, pH and concentration, type of buffer, two-step adsorption and solid-liquid ratio. As for this process, under the best conditions ([MERR][C₁C₁im]Cl (2) at pH 9, 20-fold dilution and S/L ratio of 100 mg.mL⁻¹) were obtained high purity values, 97.8% (purification factor of 3.56). With respect to the other SILs, a 2.75-fold purification (75% purity) was obtained for [MERR][C₁C₁im]Cl (1) at two-step adsorption, pH 5, 20-fold dilution and S/L ratio of 100 mg.mL⁻¹; and a 2.66-fold purification (60.8% purity) was obtained for [MERR][N₁₈₈₈]Cl at pH 7, 50-fold dilution and S/L ratio of 100 mg.mL⁻¹. In conclusion, the use of SILs was found to be promising and efficient in purifying IgG antibodies from human serum.
id RCAP_d559d8315499342ff68aeeb6e453a64c
oai_identifier_str oai:ria.ua.pt:10773/37160
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Purification of immunoglobulin G-based biopharmaceuticals using supported ionic liquidsBiopharmaceuticalsAntibodiesImmunoglobulin GDownstream processingSolid-phase extractionSupported Ionic LiquidsAntibodies are responsible for the humoral response and belong to the adaptive processes of the immune system. These properties distinguish antibodies, such as immunoglobulin G (IgG), as important proteins for scientific and clinical research, especially in the treatment of various diseases and in a variety of diagnostic tests. Thus, the production of therapeutic antibodies must be subject to strict criteria of efficiency and safety, which requires a high degree of purity. However, this process is associated with a high cost, due to the currently used downstream processing, which has been a major obstacle to the widespread application of antibodies. Therefore, the development of new cost-effective methods is crucial, where solid phase extraction has proven to be effective. Thus, in this work, resin-based supported ionic liquids (SILs) were investigated for the extraction and purification of IgG polyclonal antibodies, and the effect of the chemical structure of the ionic liquids (ILs), the operating conditions of extraction and purification were optimized to improve IgG yield and purity. In this dissertation, SILs ([MERR][C₁C₁im]Cl (1), ([MERR][C₁C₁im]Cl (2), and [MERR][N₁₈₈₈]Cl) were first synthesized and characterized. Then, a study was carried out with pure solutions of IgG and HSA to evaluate the adsorption capacity on SILs. For this assay, the best result in the adsorption of pure IgG was for Merrifield resin (pH 7, 75-fold dilution), with adsorption yield on the material of 96, 1%. Subsequently, the adsorption was studied in a binary mixture of IgG and HSA, with a purification value obtained of 1.77 for the IgG adsorbed on the material [MERR][C₁C₁im]Cl (1), at pH 4 and 50-fold dilution. Finally, the operational conditions for adsorption of IgG in human serum were studied and optimized, namely the effect of material synthesis, pH and concentration, type of buffer, two-step adsorption and solid-liquid ratio. As for this process, under the best conditions ([MERR][C₁C₁im]Cl (2) at pH 9, 20-fold dilution and S/L ratio of 100 mg.mL⁻¹) were obtained high purity values, 97.8% (purification factor of 3.56). With respect to the other SILs, a 2.75-fold purification (75% purity) was obtained for [MERR][C₁C₁im]Cl (1) at two-step adsorption, pH 5, 20-fold dilution and S/L ratio of 100 mg.mL⁻¹; and a 2.66-fold purification (60.8% purity) was obtained for [MERR][N₁₈₈₈]Cl at pH 7, 50-fold dilution and S/L ratio of 100 mg.mL⁻¹. In conclusion, the use of SILs was found to be promising and efficient in purifying IgG antibodies from human serum.Os anticorpos são responsáveis pela resposta humoral e pertencem aos processos adaptativos do sistema imune. Estas propriedades distinguem os anticorpos, como a imunoglobulina G (IgG), como proteínas importantes para a investigação científica e clínica, especialmente no tratamento de diversas doenças e, numa variedade de testes diagnósticos. Deste modo, a produção de anticorpos terapêuticos deve submeter-se a critérios rígidos de eficiência e segurança, o que exige um elevado grau de pureza. No entanto, este processo está associado a um elevado custo, devido ao processamento a jusante atualmente usado, o que tem sido um grande obstáculo para a aplicação generalizada de anticorpos. Portanto, o desenvolvimento de novos métodos económicos é crucial, onde a extração em fase sólida provou ser eficaz. Deste modo, neste trabalho, líquidos iónicos suportados (LISs) à base de resina foram investigados para a extração e a purificação de anticorpos policlonais IgG, e o efeito da estrutura química dos líquidos iónicos (LIs), das condições operacionais de extração e de purificação foram otimizadas, para melhorar o rendimento e a pureza de IgG. Nesta dissertação, LIs ([MERR][C₁C₁im]Cl (1), ([MERR][C₁C₁im]Cl (2), e [MERR][N₁₈₈₈]Cl) foram primeiramente sintetizados e caracterizados. Seguidamente, foi realizado um estudo com soluções puras de IgG e de HSA para avaliar a capacidade de adsorção nos LISs. Para este ensaio, o melhor resultado em relação à adsorção de IgG puro foi para resina Merrifield (pH 7, diluição de 75 vezes), com rendimento de adsorção no material de 96,1%. Posteriormente, a adsorção foi estudada numa mistura binária de IgG e HSA, com um valor de purificação obtido de 1.77 para a IgG adsorvida no material [MERR][C₁C₁im]Cl (1), a pH 4 e diluição de 50 vezes. Por fim, as condições operacionais de adsorção de IgG no soro humano foram estudadas e otimizadas, nomeadamente o efeito da síntese do material, pH e concentração, tipo de tampão, adsorção em duas etapas e razão sólido-líquido. Quanto este processo, nas melhores condições ([MERR][C₁C₁im]Cl (2) a pH 9, diluição de 20 vezes e razão S/L de 100 mg.mL⁻¹) foram obtidos valores de pureza elevados, 97.8% (fator de purificação de 3.56). Em relação aos demais SILs, obteve-se uma purificação de 2.75 vezes (pureza de 75.0%) para [MERR][C₁C₁im]Cl (1), numa adsorção em dois passos, a pH 5, diluição de 20 vezes e razão S/L de 100 mg.mL⁻¹; e uma purificação de 2,66 vezes (pureza de 60.8%) para [MERR][N₁₈₈₈]Cl a pH 7, diluição de 50 vezes e razão S/L de 100 mg.mL⁻¹. Em conclusão, o uso de LISs é promissor e eficiente no processo de purificação de anticorpos IgG a partir do soro humano.2024-12-27T00:00:00Z2022-12-16T00:00:00Z2022-12-16info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10773/37160engCastro, Mariana Meireles einfo:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-05-06T04:44:24Zoai:ria.ua.pt:10773/37160Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-05-06T04:44:24Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Purification of immunoglobulin G-based biopharmaceuticals using supported ionic liquids
title Purification of immunoglobulin G-based biopharmaceuticals using supported ionic liquids
spellingShingle Purification of immunoglobulin G-based biopharmaceuticals using supported ionic liquids
Castro, Mariana Meireles e
Biopharmaceuticals
Antibodies
Immunoglobulin G
Downstream processing
Solid-phase extraction
Supported Ionic Liquids
title_short Purification of immunoglobulin G-based biopharmaceuticals using supported ionic liquids
title_full Purification of immunoglobulin G-based biopharmaceuticals using supported ionic liquids
title_fullStr Purification of immunoglobulin G-based biopharmaceuticals using supported ionic liquids
title_full_unstemmed Purification of immunoglobulin G-based biopharmaceuticals using supported ionic liquids
title_sort Purification of immunoglobulin G-based biopharmaceuticals using supported ionic liquids
author Castro, Mariana Meireles e
author_facet Castro, Mariana Meireles e
author_role author
dc.contributor.author.fl_str_mv Castro, Mariana Meireles e
dc.subject.por.fl_str_mv Biopharmaceuticals
Antibodies
Immunoglobulin G
Downstream processing
Solid-phase extraction
Supported Ionic Liquids
topic Biopharmaceuticals
Antibodies
Immunoglobulin G
Downstream processing
Solid-phase extraction
Supported Ionic Liquids
description Antibodies are responsible for the humoral response and belong to the adaptive processes of the immune system. These properties distinguish antibodies, such as immunoglobulin G (IgG), as important proteins for scientific and clinical research, especially in the treatment of various diseases and in a variety of diagnostic tests. Thus, the production of therapeutic antibodies must be subject to strict criteria of efficiency and safety, which requires a high degree of purity. However, this process is associated with a high cost, due to the currently used downstream processing, which has been a major obstacle to the widespread application of antibodies. Therefore, the development of new cost-effective methods is crucial, where solid phase extraction has proven to be effective. Thus, in this work, resin-based supported ionic liquids (SILs) were investigated for the extraction and purification of IgG polyclonal antibodies, and the effect of the chemical structure of the ionic liquids (ILs), the operating conditions of extraction and purification were optimized to improve IgG yield and purity. In this dissertation, SILs ([MERR][C₁C₁im]Cl (1), ([MERR][C₁C₁im]Cl (2), and [MERR][N₁₈₈₈]Cl) were first synthesized and characterized. Then, a study was carried out with pure solutions of IgG and HSA to evaluate the adsorption capacity on SILs. For this assay, the best result in the adsorption of pure IgG was for Merrifield resin (pH 7, 75-fold dilution), with adsorption yield on the material of 96, 1%. Subsequently, the adsorption was studied in a binary mixture of IgG and HSA, with a purification value obtained of 1.77 for the IgG adsorbed on the material [MERR][C₁C₁im]Cl (1), at pH 4 and 50-fold dilution. Finally, the operational conditions for adsorption of IgG in human serum were studied and optimized, namely the effect of material synthesis, pH and concentration, type of buffer, two-step adsorption and solid-liquid ratio. As for this process, under the best conditions ([MERR][C₁C₁im]Cl (2) at pH 9, 20-fold dilution and S/L ratio of 100 mg.mL⁻¹) were obtained high purity values, 97.8% (purification factor of 3.56). With respect to the other SILs, a 2.75-fold purification (75% purity) was obtained for [MERR][C₁C₁im]Cl (1) at two-step adsorption, pH 5, 20-fold dilution and S/L ratio of 100 mg.mL⁻¹; and a 2.66-fold purification (60.8% purity) was obtained for [MERR][N₁₈₈₈]Cl at pH 7, 50-fold dilution and S/L ratio of 100 mg.mL⁻¹. In conclusion, the use of SILs was found to be promising and efficient in purifying IgG antibodies from human serum.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-16T00:00:00Z
2022-12-16
2024-12-27T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/37160
url http://hdl.handle.net/10773/37160
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1817543849206087680